Evidence map›Paper›PMID 35357241›Full record

ArticleMicrobiology spectrum2022

An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.

Javier Martínez-Sanz, María Jesús Vivancos-Gallego, Borja Manuel Fernández-Felix, Alfonso Muriel, Pilar Pérez-Elías, Almudena Uranga, Beatriz Romero, Juan Carlos Galán, Santiago Moreno, María Jesús Pérez-Elías

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Javier Martínez-SanzDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.ORCID 0000-0003-2020-3908
María Jesús Vivancos-GallegoDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.
Borja Manuel Fernández-FelixClinical Biostatistics Unit, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.
Alfonso MurielClinical Biostatistics Unit, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.
Pilar Pérez-ElíasCentro de Salud García Noblejas, Madrid, Spain.
Almudena UrangaCentro de Salud García Noblejas, Madrid, Spain.
Beatriz RomeroCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Juan Carlos GalánCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Santiago MorenoDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.
María Jesús Pérez-ElíasDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajalgrid.411347.4, IRYCIS, Madrid, Spain.
Centro de Investigación Biomédica en Red · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the effectiveness of available treatments, hepatitis C virus (HCV) remains a major public health problem, mainly due to the high percentage of undiagnosed individuals. We aim to create an easy-to-implement risk score to facilitate targeted HCV testing in the general population. This is a substudy derived from a prospective study in primary care in Madrid (Spain). Participants completed a 21-question risk assessment questionnaire, followed by HCV testing for those with at least one positive response and those >50 years of age, even if they did not answer positively. We used the population >50 years of age to fit a logistic regression model to create a score predicting the risk of a positive test result. We then performed a sensitivity analysis by applying the score obtained to the population <50 years of age, to assess its diagnostic accuracy. Data collected from 2,302 participants were included in the analysis. The prevalence of HCV infection was 1.3%. Five items were selected, showing a C-statistic of 0.896, i.e., male sex, Eastern European origin, use of intravenous drugs, self-perceived risk of acquired HCV infection, and past hepatitis or unexplained liver disease. The sensitivity was 98%, and the negative likelihood ratio was 0.05 for participants with scores of 0 (49.8% in our sample), ruling out HCV infection with high probability. We obtained similar estimates in the population <50 years of age. This tool achieved high diagnostic accuracy to target HCV testing. This could help optimize resources when universal screening is not feasible.

Indexed as

HepacivirusHepatitis CHumansMaleMass ScreeningProspective StudiesRisk Factorshepatitis C virusrisk factorsscoretargeted screeningtesting

Identifiers

PMID35357241
PMCPMC9045242
OpenAlexW4220828375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.